ACADIA Pharmaceuticals (ACAD) Earnings Date, Estimates & Call Transcripts $21.98 +0.43 (+2.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$21.62 -0.37 (-1.66%) As of 05/23/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACADIA Pharmaceuticals Earnings Summary ACADIA Pharmaceuticals posted Q1 2025 earnings on May 7, 2025, reporting an EPS of $0.11, which beat the consensus estimate of $0.10 by $0.01. Quarterly revenue rose 18.7% year-over-year to $244.32 million, above analysts' expectations of $239.32 million. With a trailing EPS of $1.37 and a P/E Ratio of 28.18, ACADIA Pharmaceuticals' earnings are expected to grow 8.57% next year, from $0.70 to $0.76 per share. Upcoming Q2 Earnings DateAug. 5After Market ClosesEstimatedConsensus EPS (May. 7) $0.10 Actual EPS (May. 7) $0.11 Beat By $0.01 Actual Revenue (May. 7) $244.32MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)ACAD Upcoming EarningsACADIA Pharmaceuticals' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get ACADIA Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ACADIA Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataACAD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACAD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ACADIA Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20253$0.09$0.10$0.10Q2 20253$0.11$0.19$0.15Q3 20253$0.15$0.20$0.17Q4 20253$0.13$0.21$0.18 FY 2025 12 $0.48 $0.70 $0.60 Q1 20261$0.10$0.10$0.10Q2 20261$0.26$0.26$0.26Q3 20261$0.32$0.32$0.32Q4 20261$0.33$0.33$0.33 ACADIA Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)--------5/7/2025Q1 2025$0.10$0.11+$0.01$0.11$239.32M$244.32M11/6/2024Q3 2024$0.14$0.20+$0.06$0.20$248.83M$250.40M8/6/2024Q2 2024$0.18$0.20+$0.02$0.20$235.95M$241.96M5/8/2024Q1 2024$0.04$0.10+$0.06$0.10$208.31M$205.83M2/27/2024Q4 2023$0.32$0.28 -$0.04$0.28$223.79M$231.04M11/2/2023Q3 2023-$0.43-$0.40+$0.03-$0.40$194.40M$211.70M8/2/2023Q2 2023-$0.12$0.01+$0.13$0.01$163.86M$165.20M ACADIA Pharmaceuticals Earnings - Frequently Asked Questions When is ACADIA Pharmaceuticals's earnings date? ACADIA Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on ACAD's earnings history. What guidance has ACADIA Pharmaceuticals issued on next quarter's earnings? ACADIA Pharmaceuticals issued an update on its FY 2025 earnings guidance on Wednesday, May, 7th. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Did ACADIA Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ACADIA Pharmaceuticals (NASDAQ:ACAD) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.10 by $0.01. Learn more on analysts' earnings estimate vs. ACAD's actual earnings. How can I listen to ACADIA Pharmaceuticals's earnings conference call? The conference call for ACADIA Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read ACADIA Pharmaceuticals's conference call transcript? The conference call transcript for ACADIA Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does ACADIA Pharmaceuticals generate each year? ACADIA Pharmaceuticals (NASDAQ:ACAD) has a recorded annual revenue of $996.28 million. How much profit does ACADIA Pharmaceuticals generate each year? ACADIA Pharmaceuticals (NASDAQ:ACAD) has a recorded net income of -$61.29 million. ACAD has generated $1.37 earnings per share over the last four quarters. What is ACADIA Pharmaceuticals's price-to-earnings ratio? ACADIA Pharmaceuticals (NASDAQ:ACAD) has a trailing price-to-earnings ratio of 28.18 and a forward price-to-earnings ratio of 31.40. What is ACADIA Pharmaceuticals's EPS forecast for next year? ACADIA Pharmaceuticals's earnings are expected to grow from $0.70 per share to $0.76 per share in the next year, which is a 8.57% increase. More Earnings Resources from MarketBeat Related Companies Intra-Cellular Therapies Earnings Date Genmab A/S Earnings Date Dr. Reddy's Laboratories Earnings Date Viatris Earnings Date Moderna Earnings Date Ascendis Pharma A/S Earnings Date Qiagen Earnings Date Roivant Sciences Earnings Date Revolution Medicines Earnings Date Elanco Animal Health Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout? This page (NASDAQ:ACAD) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACAD Stock Free ACAD Stock Alerts